Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223866 · ClinicalTrials.gov registry record · NA
The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage
A NA study, sponsored by Matthew Rauen.
- Not yet
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT07223866: Clinical Trial NA study, sponsored by Matthew Rauen.
NCT07223866 is a NA study that has not yet begun recruiting, run by Matthew Rauen. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07223866, a NA study, has not yet begun recruiting, sponsored by Matthew Rauen.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The study will pertain to investigating the impact of high vs low IOP on the intraoperative experience and comfort for the patient and surgeon. Our hypothesis is that operating at a more physiological IOP using Unity VCS/CS and Centurion with Active Sentry at a higher, or more traditional IOP will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication and lower VAS scores.
Primary Outcome
Percent of pts in each group requiring rescue medication for breakthrough discomfort/pain
Interventions
- DEVICE High IOP Setting
- DEVICE Low IOP Setting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What is known before NCT07223866 opens enrollment
NCT07223866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which High IOP Setting is the first listed.
NCT07223866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07223866 about?
NCT07223866 is a clinical study titled "The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage". The study will pertain to investigating the impact of high vs low IOP on the intraoperative experience and comfort for the patient and surgeon. Our hypothesis is that operating at a more physiological IOP using Unity VCS/CS and Centurion with Active Sentry at a higher, or more traditional IOP will r...
What is the current status of trial NCT07223866?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-11-01. Estimated completion is 2027-01-01.
What interventions are being tested in trial NCT07223866?
The interventions under investigation include: High IOP Setting (DEVICE), Low IOP Setting (DEVICE).
Who is sponsoring clinical trial NCT07223866?
This trial is sponsored by Matthew Rauen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07223866's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI